| Oscar Insurance Guidelines | Dupixent dupilumab | 2025-10-01 |
| Oscar Insurance Guidelines | Vemlidy tenofovir alafenamide | 2025-10-01 |
| Oscar Insurance Guidelines | rosuvastatin Crestor | 2025-10-01 |
| Oscar Insurance Guidelines | Omega-3-acid ethyl esters Lovaza | 2025-10-01 |
| BCBS Texas Medical Policies | Chromoendoscopy as an Adjunct to Colonoscopy | 2025-10-01 |
| BCBS Texas Medical Policies | Surface Electromyography and Paraspinal Surface | 2025-10-01 |
| Aetna | Salivary Tests | 2025-10-01 |
| Aetna | Adoptive Immunotherapy and Cellular Therapy | 2025-10-01 |
| UHC Medicare Advantage | Durable Medical Equipment (DME), Prosthetics, Orthotics (Non-Foot Orthotics), Nutritional Therapy, and Medical Supplies Grid – Medicare Advantage Medical Policy | 2025-10-01 |
| UHC UMR Medical and Drug | Antiemetics for Oncology – Commercial Medical Benefit Drug Policy | 2025-10-01 |